Myelodysplastic Syndrome
News
Predicting transformation from MDS to AML
Photo courtesy of McMaster University Research published in Cancer Cell suggests a molecular signature can be used to predict which patients with...
Conference Coverage
Chemo quadruples risk for myeloid cancers
Key clinical point: This study quantifies the risks for treatment-related myeloid cancers after chemotherapy. Major finding: Chemotherapy is...
Conference Coverage
VIDEO: High-intensity conditioning stands ground in MDS, AML
News
FDA approves generic imatinib
Photo by Steven Harbour The US Food and Drug Administration (FDA) has approved the use of imatinib mesylate, a generic version of Novartis’s...
News
A new category of cytopenias
New research suggests that clonality may underlie the cytopenias observed in patients with idiopathic cytopenias of undetermined significance (...
News
Blood cancer drugs set to be removed from CDF
Photo courtesy of CDC England’s National Health Service (NHS) plans to remove several drugs used to treat hematologic malignancies from the...
Video
Heme Themes: Transplant timing for myelofibrosis in the era of JAK2 inhibitors
Video
Heme Themes: Challenges in averting the progression of MPN, MDS
News
Imetelstat elicits response in myelofibrosis, thrombocythemia
Key clinical point: The telomerase inhibitor imetelstat showed promise in separate preliminary studies for treatment of myelofibrosis and...
News
New HMA shows early promise for MDS/AML
Image by Christoph Bock Investigators say a novel hypomethylating agent (HMA) is safe and clinically active in patients with myelodysplastic...
News
Lenalidomide can treat pulmonary sarcoidosis in MDS
Treatment with lenalidomide can have a significant effect on pulmonary sarcoidosis in myelodysplastic syndrome (MDS), according to a case study....